Clinical Evidence
254 results
HDx therapy enabled by Theranova
Performance of medium cut-off dialyzers in expanded hemodialysis patients in Colombia
PD
Perspectives from the Kidney Health Initiative on Advancing Technologies to Facilitate Remote Monitoring of Patient Self-Care in RRT - Rosner et al.
HDx therapy enabled by Theranova
Prevalence of fatigue reported by patients on hemodialysis therapy
HDx therapy enabled by Theranova
Pro-calcifying analysis of uraemic serum from patients treated with medium cut-off membrane in a prospective, cross-over study
HDx therapy enabled by Theranova
Protein bound drug removal by membranes of different albumin permeability
HDx therapy enabled by Theranova
Pushing the boundaries of hemodialysis: innovations in membranes and sorbents
HDx therapy enabled by Theranova
Pyrogen retention: Comparison of the novel medium cut-off (MCO) membrane with other dialyser membranes
HDx therapy enabled by Theranova
Quantification of Internal Filtration in Hollow Fiber Hemodialyzers with Medium Cut-Off Membrane
HDx therapy enabled by Theranova
Rationale for a New Classification of Solutes of Interest in Chronic Kidney Disease and Hemodialysis
HDx therapy enabled by Theranova
Rationale for Medium Cutoff Membranes in COVID-19 Patients Requiring Renal Replacement Therapy
Vantive is a trademark of Vantive Health LLC or its affiliates.